Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-44
Closed -$3K 876
2020
Q2
$3K Sell
44
-123
-74% -$6.91K ﹤0.01% 639
2020
Q1
$7K Hold
167
﹤0.01% 474
2019
Q4
$8K Hold
167
﹤0.01% 495
2019
Q3
$5K Hold
167
﹤0.01% 565
2019
Q2
$5K Sell
167
-43
-20% -$1.38K ﹤0.01% 543
2019
Q1
$7K Sell
210
-23
-10% -$849 ﹤0.01% 498
2018
Q4
$9K Buy
233
+117
+101% +$4.27K ﹤0.01% 462
2018
Q3
$5K Hold
116
﹤0.01% 616
2018
Q2
$5K Hold
116
﹤0.01% 561
2018
Q1
$3K Sell
116
-64
-36% -$1.38K ﹤0.01% 731
2017
Q4
$4K Hold
180
﹤0.01% 606
2017
Q3
$4K Hold
180
﹤0.01% 632
2017
Q2
$3K Hold
180
﹤0.01% 748
2017
Q1
$3K Sell
180
-25
-12% -$386 ﹤0.01% 780
2016
Q4
$3K Hold
205
﹤0.01% 813
2016
Q3
$2K Buy
+205
New +$2.22K ﹤0.01% 892

Other funds holding VICR

Howe & Rusling's VICR Position: Q3 2020 in Review

Howe & Rusling sold out of Vicor (VICR) in Q3 2020, closing a stake of 44 shares — an estimated $3K sold.

Howe & Rusling first reported a position in VICR in Q3 2016 and held it in 16 quarters. The position peaked at $9K in Q4 2018. 177 funds tracked by Wall St. Rank hold VICR as of Q3 2020.

  • Howe & Rusling reported no remaining Vicor position as of Q3 2020 after selling out during the quarter.
  • Howe & Rusling sold 44 Vicor shares in Q3 2020, an estimated $3K.
  • Howe & Rusling first reported a position in Vicor in Q3 2016 and held it in 16 quarters.
  • Howe & Rusling's Vicor position peaked at $9K in Q4 2018.
  • 177 funds tracked by Wall St. Rank held Vicor as of Q3 2020.

Based on Howe & Rusling's 13F filing for Q3 2020, filed 6 Nov 2020.